No Data
Three key points to focus on in the morning session ~ Analyzing the market development to determine the firmness after the sell-off ~
In the morning session of the 29th, attention should be focused on the following three points: - Market development to determine the firmness after the round of selling - Futudent, 2Q upward revision Operating profit 0.219 billion yen ← 0.141 billion yen - Morning session focus: First Kogyo Pharmaceuticals, chemical synthesis with light, verification in Shiga - The Japanese stock market on the 29th is likely to see a market development to determine the firmness after the round of selling. The U.S. market on the 28th saw the Dow Jones Industrial Average down 159 points and the Nasdaq down 198 points.
Daiichi Kogyo Pharmaceuticals, TPR, etc. [List of stock materials from newspapers]
*Daiichi Sankyo <4461>: Chemical synthesis using light, verified in Shiga (Nikkan Kogyo, page 3) -○ *Rhythm <7769>: Dissolving a US watch sales company, promoting structural reform (Nikkan Kogyo, page 3) -○ *Kirin HD <2503>: Extension of TOB period to Fancl (Nikkan Kogyo, page 3) -○ *TPR <6463>: Developing a development base in the Tokyo metropolitan area, expanding into new fields such as EV components with 100 people (Nikkan Kogyo, page 9) -○ *SUBARU <7270>: Local 5G equipment at the test site, first among domestic automakers (Nikkan Kogyo, page 9) -○ *
Rhythm: Financial report for the first quarter of the fiscal year ending March 2025 [based on Japanese standards] (consolidated).
List of conversion stocks [List of conversion stocks for parabolic signals]
List of buy conversion stocks in the market: Code Company name End price SAR 3836 AvantG 1426 1200 4215 TakilonCI 895 728 4689 LineYahoo 339 339 7769 Rhythm 3830 3445 9302 MitsuiWarehouseHD 4560 4530 List of sell conversion stocks in the market: Code Company name
Rhythm: Interim report
Rhythm: Confirmation letter
No Data
